Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mu-type opioid receptor | ||
Ligand | BDBM469458 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Human Mu-Opioid Peptide (hMOP) Receptor Binding Assay | ||
Ki | 1.000±n/a nM | ||
Citation | Kuehnert, S; Koenigs, R; Kless, A; Wegert, A; Konetzki, I; Ratcliffe, P; Jostock, R; Koch, T; Linz, K; Schroeder, W 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives US Patent US10807988 Publication Date 10/20/2020 | ||
More Info.: | Get all data from this article, Assay Method | ||
Mu-type opioid receptor | |||
Name: | Mu-type opioid receptor | ||
Synonyms: | M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1 | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 44789.51 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P35372 | ||
Residue: | 400 | ||
Sequence: |
| ||
BDBM469458 | |||
n/a | |||
Name | BDBM469458 | ||
Synonyms: | US10807988, Example SC_3100 | cis-8-Dimethylamino-1-[(1-hydroxy-cyclobutyl)-methyl]-8-phenyl-3-(2-piperazin- 1-yl-pyrimidin-5-yl)-1,3-diazaspiro[4.5]decan-2-one hydrochloride | ||
Type | Small organic molecule | ||
Emp. Form. | C29H41N7O2 | ||
Mol. Mass. | 519.6815 | ||
SMILES | CN(C)[C@]1(CC[C@]2(CN(C(=O)N2CC2(O)CCC2)c2cnc(nc2)N2CCNCC2)CC1)c1ccccc1 |r,wU:6.11,3.2,(5.13,-7.04,;5.9,-8.37,;7.44,-8.37,;5.13,-9.7,;4.36,-11.04,;2.82,-11.04,;2.05,-9.7,;1.15,-8.46,;-.32,-8.93,;-.32,-10.47,;-1.57,-11.38,;1.15,-10.95,;1.62,-12.41,;.59,-13.56,;2.08,-13.96,;-.95,-13.56,;-.95,-15.1,;.59,-15.1,;-1.5,-7.94,;-2.94,-8.46,;-4.12,-7.47,;-3.85,-5.95,;-2.4,-5.43,;-1.22,-6.42,;-5.03,-4.96,;-4.75,-3.44,;-5.93,-2.45,;-7.38,-2.97,;-7.65,-4.49,;-6.47,-5.48,;2.82,-8.37,;4.36,-8.37,;5.9,-11.04,;5.13,-12.37,;5.9,-13.7,;7.44,-13.7,;8.21,-12.37,;7.44,-11.04,)| | ||
Structure |